Free Trial

Barclays Has Lowered Expectations for Cushman & Wakefield (NYSE:CWK) Stock Price

Cushman & Wakefield logo with Real Estate background
Image from MarketBeat Media, LLC.

Key Points

  • Barclays cut its price target on Cushman & Wakefield from $16 to $15 while maintaining an “equal weight” rating; the new target implies 13.68% upside from the stock’s current price.
  • Analyst views are mixed: the consensus rating is “Hold” with a $16.71 price target, while Goldman Sachs raised its target to $19 and Zacks Research downgraded the stock to “Strong Sell.”
  • Cushman & Wakefield reported quarterly EPS of $0.37, topping the $0.36 estimate, and revenue of $2.81 billion, above expectations and up 7.7% year over year.
  • Interested in Cushman & Wakefield? Here are five stocks we like better.

Cushman & Wakefield (NYSE:CWK - Get Free Report) had its price objective lowered by analysts at Barclays from $16.00 to $15.00 in a report released on Monday, Benzinga reports. The brokerage currently has an "equal weight" rating on the stock. Barclays's price target indicates a potential upside of 13.68% from the company's current price.

A number of other research firms have also weighed in on CWK. The Goldman Sachs Group upped their target price on shares of Cushman & Wakefield from $17.00 to $19.00 and gave the stock a "buy" rating in a report on Thursday. Weiss Ratings reissued a "hold (c)" rating on shares of Cushman & Wakefield in a report on Tuesday, November 3rd. Citigroup restated a "market outperform" rating on shares of Cushman & Wakefield in a research report on Thursday, October 22nd. Zacks Research cut shares of Cushman & Wakefield from a "hold" rating to a "strong sell" rating in a report on Friday, October 16th. Finally, UBS Group decreased their price target on shares of Cushman & Wakefield from $17.00 to $15.00 and set a "neutral" rating on the stock in a report on Monday, August 10th. Five analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $16.71.

Read Our Latest Report on CWK

Cushman & Wakefield Price Performance

CWK stock traded down $0.10 during mid-day trading on Monday, reaching $13.20. 103,152 shares of the company traded hands, compared to its average volume of 2,168,996. The company has a debt-to-equity ratio of 1.15, a current ratio of 1.06 and a quick ratio of 1.06. The company has a market capitalization of $3.10 billion, a P/E ratio of 45.50 and a beta of 1.53. Cushman & Wakefield has a 52-week low of $10.88 and a 52-week high of $17.40. The company has a fifty day moving average price of $12.55 and a 200-day moving average price of $13.28.

Cushman & Wakefield (NYSE:CWK - Get Free Report) last announced its quarterly earnings results on Wednesday, November 4th. The company reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.01. Cushman & Wakefield had a return on equity of 16.60% and a net margin of 0.63%. The firm had revenue of $2.81 billion for the quarter, compared to analysts' expectations of $2.78 billion. During the same period in the prior year, the business posted $0.29 earnings per share. The company's revenue was up 7.7% on a year-over-year basis. As a group, analysts anticipate that Cushman & Wakefield will post 1.47 earnings per share for the current year.

Insider Activity

In other news, insider Nathaniel Robinson sold 12,518 shares of the business's stock in a transaction dated Tuesday, November 10th. The stock was sold at an average price of $13.98, for a total transaction of $175,001.64. Following the completion of the transaction, the insider owned 45,858 shares of the company's stock, valued at approximately $641,094.84. The trade was a 21.44% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.74% of the company's stock.

Institutional Investors Weigh In On Cushman & Wakefield

Institutional investors and hedge funds have recently bought and sold shares of the stock. Eurizon Capital SGR S.p.A. raised its stake in shares of Cushman & Wakefield by 18.4% during the third quarter. Eurizon Capital SGR S.p.A. now owns 8,003,931 shares of the company's stock worth $94,450,000 after acquiring an additional 1,242,632 shares in the last quarter. Jennison Associates LLC bought a new stake in shares of Cushman & Wakefield in the 1st quarter worth approximately $6,672,000. Renaissance Technologies LLC bought a new stake in shares of Cushman & Wakefield in the 1st quarter worth approximately $6,101,000. Dimensional Fund Advisors LP boosted its stake in shares of Cushman & Wakefield by 3.1% in the 1st quarter. Dimensional Fund Advisors LP now owns 13,248,848 shares of the company's stock valued at $162,424,000 after purchasing an additional 397,892 shares in the last quarter. Finally, Jump Financial LLC boosted its stake in shares of Cushman & Wakefield by 78.6% in the 3rd quarter. Jump Financial LLC now owns 644,859 shares of the company's stock valued at $7,616,000 after purchasing an additional 283,859 shares in the last quarter. 95.56% of the stock is owned by hedge funds and other institutional investors.

Cushman & Wakefield Company Profile

(Get Free Report)

Cushman & Wakefield NYSE: CWK is a global commercial real estate services firm that advises property owners, occupiers, investors and developers. Its services include leasing and sales brokerage, capital markets, property and facilities management, valuation, project management and real estate consulting. The company serves clients across the Americas, Europe, the Middle East and Africa, and Asia-Pacific. Its history traces back to Cushman & Wakefield's founding in 1917, and the current company took shape in 2015 following the combination of Cushman & Wakefield and DTZ.

Further Reading

Analyst Recommendations for Cushman & Wakefield (NYSE:CWK)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cushman & Wakefield Right Now?

Before you consider Cushman & Wakefield, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cushman & Wakefield wasn't on the list.

While Cushman & Wakefield currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines